Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse
Titel:
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse
Auteur:
Orlandi, A. Calegari, M. A. Martini, M. Cocomazzi, A. BagalĂ , C. Indellicati, G. Zurlo, V. Basso, M. Cassano, A. Larocca, L. M. Barone, C.